Literature DB >> 1725767

Interferon inhibits synaptic potentiation in rat hippocampus.

G D'Arcangelo1, F Grassi, D Ragozzino, A Santoni, V Tancredi, F Eusebi.   

Abstract

The effects of rat interferon (IFN) on the electrically-induced potentiation of the synaptic transmission were studied in rat hippocampal slices by using extracellular field potential recordings. The treatment with rat IFN (120 U/ml) reduced the size of short-term potentiation (STP) and suppressed long-term potentiation (LTP). These IFN-induced effects were dose-dependent in the range of 50-500 U/ml. In addition, IFN slightly attenuated the potentiation when applied during the maintenance of LTP. Basal synaptic transmission was affected by IFN at concentrations greater than or equal to 250 U/ml. Following an acute exposure to IFN (500-200 U/ml), cultured embryonic neurones from rat hippocampus often exhibited an attenuation of N-methyl-D-aspartate-induced currents and a variation (increase or decrease) of voltage-activated Ca2+ current amplitude. A possible role of IFN as neuromodulator in mammalian brain during immune responses is discussed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1725767     DOI: 10.1016/0006-8993(91)91459-e

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  10 in total

1.  Gene discovery in genetically labeled single dopaminergic neurons of the retina.

Authors:  Stefano Gustincich; Massimo Contini; Manuela Gariboldi; Michelino Puopolo; Koji Kadota; Hidemasa Bono; Julianna LeMieux; Pamela Walsh; Piero Carninci; Yoshihide Hayashizaki; Yasushi Okazaki; Elio Raviola
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-26       Impact factor: 11.205

2.  Central and peripheral cytokines mediate immune-brain connectivity.

Authors:  Hugo O Besedovsky; Adriana del Rey
Journal:  Neurochem Res       Date:  2010-09-04       Impact factor: 3.996

3.  Altered central nervous system gene expression caused by congenitally acquired persistent infection with lymphocytic choriomeningitis virus.

Authors:  Stefan Kunz; Jillian M Rojek; Amanda J Roberts; Dorian B McGavern; Michael B A Oldstone; Juan Carlos de la Torre
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

4.  Increased IFNα activity and differential antibody response in patients with a history of Lyme disease and persistent cognitive deficits.

Authors:  Elzbieta Jacek; Brian A Fallon; Abhishek Chandra; Mary K Crow; Gary P Wormser; Armin Alaedini
Journal:  J Neuroimmunol       Date:  2012-11-08       Impact factor: 3.478

Review 5.  The pathophysiology of multiple sclerosis: the mechanisms underlying the production of symptoms and the natural history of the disease.

Authors:  K J Smith; W I McDonald
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-10-29       Impact factor: 6.237

6.  The in vivo effect of lipopolysaccharide on the spontaneous release of transmitter from motor nerve terminals.

Authors:  S H Liu; T J Sheu; R H Lin; S Y Lin-Shiau
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

7.  Prefrontal dopaminergic and enkephalinergic synaptic accommodation in HIV-associated neurocognitive disorders and encephalitis.

Authors:  Benjamin B Gelman; Joshua G Lisinicchia; Tianshen Chen; Kenneth M Johnson; Kristofer Jennings; Daniel H Freeman; Vicki M Soukup
Journal:  J Neuroimmune Pharmacol       Date:  2012-03-06       Impact factor: 4.147

8.  Novel roles for immune molecules in neural development: implications for neurodevelopmental disorders.

Authors:  Paula A Garay; A Kimberley McAllister
Journal:  Front Synaptic Neurosci       Date:  2010-09-08

9.  Regulation of interferon responses in medulloblastoma cells by interferon regulatory factor-1 and -2.

Authors:  K C Park; K Shimizu; T Hayakawa; N Tanaka
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

10.  The TNFα-Transgenic Rat: Hippocampal Synaptic Integrity, Cognition, Function, and Post-Ischemic Cell Loss.

Authors:  L Creed Pettigrew; Richard J Kryscio; Christopher M Norris
Journal:  PLoS One       Date:  2016-05-04       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.